61例不同预后弥漫性大B细胞淋巴瘤的临床特征 - Suppr | 超能文献

[Clinical characterization of 61 cases of diffuse large B-cell lymphoma with different prognosis].

作者信息

Wang Qian, Wei Xu-Dong, Yin Qing-Song

出版信息

Zhonghua Zhong Liu Za Zhi. 2012 Feb;34(2):136-7. doi: 10.3760/cma.j.issn.0253-3766.2012.02.012.

DOI:10.3760/cma.j.issn.0253-3766.2012.02.012

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Clinical characterization of 61 cases of diffuse large B-cell lymphoma with different prognosis].61例不同预后弥漫性大B细胞淋巴瘤的临床特征

Zhonghua Zhong Liu Za Zhi. 2012 Feb;34(2):136-7. doi: 10.3760/cma.j.issn.0253-3766.2012.02.012.

2

[Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].[原发性胃肠道弥漫性大B细胞淋巴瘤：90例免疫组化及预后研究]

Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):220-6.

3

Immunohistochemical expression of CD-10, BCL-6 and MUM-1 antibodies and immediate clinical response in patients of diffuse large B-cell lymphomas after six cycles of chemotherapy.弥漫性大B细胞淋巴瘤患者化疗六个周期后CD-10、BCL-6和MUM-1抗体的免疫组化表达及近期临床反应

J Coll Physicians Surg Pak. 2014 Oct;24(10):722-7. doi: 10.2014/JCPSP.722727.

4

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.年轻的非生发中心 B 细胞样弥漫性大 B 细胞淋巴瘤患者从 ACVBP 联合利妥昔单抗强化化疗中获益优于 CHOP 联合利妥昔单抗：来自 Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma 研究协会 III 期试验 LNH 03-2B 的数据分析。

J Clin Oncol. 2014 Dec 10;32(35):3996-4003. doi: 10.1200/JCO.2013.54.9493. Epub 2014 Nov 10.

5

R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma.R-CHOP方案可显著降低非生发中心B细胞亚型弥漫性大B细胞淋巴瘤患者疾病复发和进展的风险。

Chin J Cancer. 2012 Jun;31(6):306-14. doi: 10.5732/cjc.011.10420. Epub 2012 May 23.

6

[Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].[中枢神经系统原发性弥漫性大B细胞淋巴瘤的免疫组化亚型及预后分析]

Zhonghua Zhong Liu Za Zhi. 2012 Feb;34(2):110-6. doi: 10.3760/cma.j.issn.0253-3766.2012.02.007.

7

[Significance of myc gene rearrangement and its correlation with prognosis in diffuse large B cell lymphoma].[myc基因重排在弥漫性大B细胞淋巴瘤中的意义及其与预后的相关性]

Zhonghua Zhong Liu Za Zhi. 2013 Feb;35(2):119-23. doi: 10.3760/cma.j.issn.0253-3766.2013.02.009.

8

Prognostic sub-grouping of diffuse large B-cell lymphomas into germinal centre and post germinal centre groups by immunohistochemistry after 6 cycles of chemotherapy.在进行6个周期化疗后，通过免疫组织化学将弥漫性大B细胞淋巴瘤预后亚组分为生发中心组和生发中心后组。

Asian Pac J Cancer Prev. 2012;13(4):1341-7. doi: 10.7314/apjcp.2012.13.4.1341.

9

[Clinical significance of bcl-2 protein expression and classification algorithm in diffuse large B-cell lymphoma].[弥漫性大B细胞淋巴瘤中bcl-2蛋白表达及分类算法的临床意义]

Zhonghua Bing Li Xue Za Zhi. 2012 Dec;41(12):813-7. doi: 10.3760/cma.j.issn.0529-5807.2012.12.005.

10

[Clinicopathological and molecular genetic characteristics of childhood diffuse large B cell lymphoma].儿童弥漫性大B细胞淋巴瘤的临床病理及分子遗传学特征

Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):209-11. doi: 10.3760/cma.j.issn.0253-3766.2012.03.011.